Cyanotech Corp splits its revenue into 7 lines in its filings. The largest line in Q2 of fiscal 2025, the quarter ended Sep 30, 2025 was Packaged Astaxanthin at $3.3 million, 47% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2025
|
Q2 FY2025
Sep 30, 2025
|
Q1 FY2025
Jun 30, 2025
|
Q3 FY2024
Dec 31, 2024
|
Q2 FY2024
Sep 30, 2024
|
Q1 FY2024
Jun 30, 2024
|
Q4 FY2024
Mar 31, 2024
|
Q3 FY2023
Dec 31, 2023
|
Q2 FY2023
Sep 30, 2023
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
24
|
7
|
6
|
6
|
6
|
6
|
5
|
6
|
6
|
| Packaged Products |
—
|
—
|
—
|
—
|
—
|
—
|
5
share 92.1%
|
—
|
—
|
| Packaged Astaxanthin |
13
-3.6%
share 53.9%
|
3
+4.7%
share 46.8%
|
3
-9.0%
share 51.0%
|
4
-4.3%
share 57.2%
|
3
-15.6%
share 53.4%
|
3
share 55.3%
|
—
|
4
share 66.1%
|
4
share 58.0%
|
| Bulk Astaxanthin |
4
+94.6%
share 16.1%
|
2
+142.6%
share 22.0%
|
1
+49.2%
share 19.9%
|
1
+114.9%
share 9.1%
|
1
+4.1%
share 10.8%
|
1
share 13.1%
|
0
share 6.3%
|
0
share 4.7%
|
1
share 9.5%
|
| Packaged Spirulina |
5
+0.7%
share 21.4%
|
1
+20.3%
share 18.8%
|
1
-19.5%
share 19.8%
|
1
+8.2%
share 22.4%
|
1
-31.8%
share 18.6%
|
1
share 24.2%
|
1
share 25.8%
|
1
share 22.9%
|
2
share 25.0%
|
| Bulk Spirulina |
3
+41.2%
share 11.1%
|
1
+16.3%
share 11.8%
|
1
+48.0%
share 8.7%
|
0
share 8.0%
|
1
+97.8%
share 12.1%
|
0
share 5.8%
|
1
share 10.5%
|
—
|
0
share 5.6%
|
| Bulk Products |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
1
share 10.3%
|
—
|
| Contract Extraction And RD Services |
1
-31.0%
share 2.3%
|
0
-85.2%
share 0.6%
|
0
-56.5%
share 0.7%
|
0
+390.2%
share 3.3%
|
0
+156.0%
share 5.1%
|
0
share 1.6%
|
0
share 6.9%
|
0
share 0.7%
|
0
share 1.8%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CYAN (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Kailua Kona, HI
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 768408
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.